Bioprocessing White Papers

1. Improvements In ADC Efficacy And Stability 3/17/2026

   Antibody-drug conjugates combine targeted antibodies with potent cytotoxic payloads, but increasing hydrophobicity challenges stability, manufacturability, and pharmacokinetics, driving interest in hydrophilic linker strategies to improve performance.

2. A Faster Path To Genomic Medicine Feasibility 3/17/2026

   Life Edit accelerates genomic medicine by comparing five editing modalities, engineering new enzymes, and rapidly pinpointing optimal strategies that boost feasibility, cut risk, and speed clinical progress.

3. Tailoring Viral Clearance Study Design 3/4/2026

   Viral‑clearance studies need phase‑appropriate design, strong virus stocks, modality‑specific risk assessment, and alignment with evolving regulations for reliable safety outcomes.

4. Key Selection Criteria For Cell & Gene Therapy CDMOs 3/4/2026

   Choosing the right CDMO requires early internal assessment plus strong technical capability, agility, advocacy, clear communication, and long‑term alignment to meet evolving cell and gene therapy needs.

5. Alleviate Compliance Risks With Your EAM/CMMS 3/2/2026

   Discover how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.

6. A Journey To Produce MSC-Derived Cell Therapies From Isolation To Large-Scale 2/26/2026

   Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.

7. Soil Testing: From Filtration To Fertilizer To Food 2/25/2026

   Soil analysis offers a clear view of the factors that influence land productivity while helping identify contaminants that could threaten safety. Understand the indicators to support sustainability decisions.

8. How The Accelerator™ Drug Development Model Enhances eNPV 2/25/2026

   Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

9. A Comprehensive Solution For Adventitious Agent Testing 2/13/2026

   Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.

10. Collaborative Variability Reduction In Cell Culture Media 2/13/2026

    Variability reduction programs improve biomanufacturing by controlling raw‑material complexity, optimizing critical attributes, and boosting productivity through data‑driven partnerships.